• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

直肠给药系统的进展:临床试验及专利视角

Advancements in Rectal Drug Delivery Systems: Clinical Trials, and Patents Perspective.

作者信息

Rathi Ritu, Kumar Alpesh, Vishvakarma Vivekanand, Huanbutta Kampanart, Singh Inderbir, Sangnim Tanikan

机构信息

Chitkara College of Pharmacy, Chitkara University, Rajpura 140401, India.

School of Pharmacy, Eastern Asia University, Pathumthani 12110, Thailand.

出版信息

Pharmaceutics. 2022 Oct 17;14(10):2210. doi: 10.3390/pharmaceutics14102210.

DOI:10.3390/pharmaceutics14102210
PMID:36297645
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9609333/
Abstract

The rectal route is an effective route for the local and systemic delivery of active pharmaceutical ingredients. The environment of the rectum is relatively constant with low enzymatic activity and is favorable for drugs having poor oral absorption, extensive first-pass metabolism, gastric irritation, stability issues in the gastric environment, localized activity, and for drugs that cannot be administered by other routes. The present review addresses the rectal physiology, rectal diseases, and pharmaceutical factors influencing rectal delivery of drugs and discusses different rectal drug delivery systems including suppositories, suspensions, microspheres, nanoparticles, liposomes, tablets, and hydrogels. Clinical trials on various rectal drug delivery systems are presented in tabular form. Applications of different novel drug delivery carriers viz. nanoparticles, liposomes, solid lipid nanoparticles, microspheres, transferosomes, nano-niosomes, and nanomicelles have been discussed and demonstrated for their potential use in rectal administration. Various opportunities and challenges for rectal delivery including recent advancements and patented formulations for rectal drug delivery have also been included.

摘要

直肠给药途径是活性药物成分局部和全身递送的有效途径。直肠环境相对稳定,酶活性低,有利于口服吸收差、首过代谢广泛、有胃刺激、在胃环境中稳定性差、局部活性的药物,以及不能通过其他途径给药的药物。本综述阐述了直肠生理学、直肠疾病以及影响药物直肠递送的药学因素,并讨论了不同的直肠给药系统,包括栓剂、混悬剂、微球、纳米粒、脂质体、片剂和水凝胶。以表格形式呈现了各种直肠给药系统的临床试验。讨论并展示了不同新型药物递送载体,即纳米粒、脂质体、固体脂质纳米粒、微球、传递体、纳米囊泡和纳米胶束在直肠给药中的潜在应用。还包括了直肠给药的各种机遇和挑战,包括直肠给药的最新进展和专利制剂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daf1/9609333/4850351ca693/pharmaceutics-14-02210-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daf1/9609333/f7d64af33814/pharmaceutics-14-02210-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daf1/9609333/10f24b36af46/pharmaceutics-14-02210-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daf1/9609333/a34cf2b1cf35/pharmaceutics-14-02210-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daf1/9609333/4850351ca693/pharmaceutics-14-02210-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daf1/9609333/f7d64af33814/pharmaceutics-14-02210-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daf1/9609333/10f24b36af46/pharmaceutics-14-02210-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daf1/9609333/a34cf2b1cf35/pharmaceutics-14-02210-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daf1/9609333/4850351ca693/pharmaceutics-14-02210-g004.jpg

相似文献

1
Advancements in Rectal Drug Delivery Systems: Clinical Trials, and Patents Perspective.直肠给药系统的进展:临床试验及专利视角
Pharmaceutics. 2022 Oct 17;14(10):2210. doi: 10.3390/pharmaceutics14102210.
2
Physiological and Pharmaceutical Considerations for Rectal Drug Formulations.直肠给药制剂的生理学和药学考量
Front Pharmacol. 2019 Oct 16;10:1196. doi: 10.3389/fphar.2019.01196. eCollection 2019.
3
Pharmacokinetics of rectal drug administration, Part I. General considerations and clinical applications of centrally acting drugs.直肠给药的药代动力学,第一部分。中枢作用药物的一般考虑因素和临床应用。
Clin Pharmacokinet. 1991 Jul;21(1):11-26. doi: 10.2165/00003088-199121010-00002.
4
Advances in rectal drug delivery systems.直肠给药系统的进展。
Pharm Dev Technol. 2018 Dec;23(10):942-952. doi: 10.1080/10837450.2018.1484766. Epub 2018 Jul 24.
5
Recent Advancements and Patents on Buccal Drug Delivery Systems: A Comprehensive Review.口腔药物传递系统的最新进展和专利:全面综述。
Recent Pat Nanotechnol. 2022;16(4):308-325. doi: 10.2174/1872210515666210609145144.
6
Nasal route and drug delivery systems.鼻内给药途径与给药系统。
Pharm World Sci. 2004 Jun;26(3):137-42. doi: 10.1023/b:phar.0000026823.82950.ff.
7
A Comprehensive Review of Challenges in Oral Drug Delivery Systems and Recent Advancements in Innovative Design Strategies.口服给药系统中的挑战及创新设计策略的最新进展综述
Curr Pharm Des. 2025;31(5):360-376. doi: 10.2174/0113816128338560240923073357.
8
Advancements and Avenues in Nanophytomedicines for Better Pharmacological Responses.纳米植物药实现更好药理反应的进展与途径
J Nanosci Nanotechnol. 2015 Jun;15(6):4070-9. doi: 10.1166/jnn.2015.10333.
9
An Update of Patents, Preclinical and Clinical Outcomes of Lipid Nanoparticulate Systems.脂质纳米颗粒系统的专利、临床前和临床结果的最新情况
Curr Pharm Des. 2017 Nov 21. doi: 10.2174/1381612823666171122104216.
10
Proniosomes derived niosomes: recent advancements in drug delivery and targeting.前体脂质体衍生的尼莫体:药物传递和靶向的最新进展。
Drug Deliv. 2017;24(sup1):56-69. doi: 10.1080/10717544.2017.1384520.

引用本文的文献

1
Polymeric nanomaterials as a drug delivery system for anticancer and antibacterial infections: a review.聚合物纳米材料作为抗癌和抗菌感染的药物递送系统:综述
RSC Adv. 2025 Sep 9;15(39):32572-32592. doi: 10.1039/d5ra01788b. eCollection 2025 Sep 5.
2
Development of Low-Dose Disulfiram Rectal Suppository Intended for Application in Post-Treatment Lyme Disease Syndrome.用于治疗莱姆病后综合征的低剂量双硫仑直肠栓剂的研发。
Pharmaceutics. 2025 Jun 28;17(7):849. doi: 10.3390/pharmaceutics17070849.
3
Emerging for non-invasive heparin delivery systems: recent advances, barriers, solutions, and applicability.

本文引用的文献

1
Preparation, in vitro and in vivo Evaluation of Thermosensitive in situ Gel Loaded with Ibuprofen-Solid Lipid Nanoparticles for Rectal Delivery.制备、体外和体内评价布洛芬固体脂质纳米粒温敏原位凝胶直肠给药制剂。
Drug Des Devel Ther. 2022 May 12;16:1407-1431. doi: 10.2147/DDDT.S350886. eCollection 2022.
2
Development of Stable Nano-Sized Transfersomes as a Rectal Colloid for Enhanced Delivery of Cannabidiol.开发稳定的纳米级传递体作为直肠胶体以增强大麻二酚的递送。
Pharmaceutics. 2022 Mar 25;14(4):703. doi: 10.3390/pharmaceutics14040703.
3
Development, Characterization, and Evaluation of SLN-Loaded Thermoresponsive Hydrogel System of Topotecan as Biological Macromolecule for Colorectal Delivery.
新兴的非侵入性肝素递送系统:最新进展、障碍、解决方案及适用性
Saudi Pharm J. 2025 Jun 12;33(3):17. doi: 10.1007/s44446-025-00022-6.
4
Exploring the therapeutic role of Moringa oleifera in neurodegeneration: antioxidant, anti-inflammatory, and neuroprotective mechanisms.探索辣木在神经退行性变中的治疗作用:抗氧化、抗炎和神经保护机制。
Inflammopharmacology. 2025 May 31. doi: 10.1007/s10787-025-01794-y.
5
Neurotropic Effects of Cortexin on Models of Mental and Physical Developmental Delay.皮质素对精神和身体发育迟缓模型的神经营养作用。
Biomedicines. 2025 Apr 2;13(4):860. doi: 10.3390/biomedicines13040860.
6
Evaluation of Drug Permeation Enhancement by Using In Vitro and Ex Vivo Models.使用体外和离体模型评估药物渗透增强作用
Pharmaceuticals (Basel). 2025 Jan 31;18(2):195. doi: 10.3390/ph18020195.
7
Advanced Drug Delivery Technologies for Enhancing Bioavailability and Efficacy of Risperidone.用于提高利培酮生物利用度和疗效的先进药物递送技术
Int J Nanomedicine. 2024 Nov 30;19:12871-12887. doi: 10.2147/IJN.S492684. eCollection 2024.
8
Advancements in cyclodextrin-based controlled drug delivery: Insights into pharmacokinetic and pharmacodynamic profiles.基于环糊精的控释药物递送的进展:对药代动力学和药效学特征的见解。
Heliyon. 2024 Oct 30;10(21):e39917. doi: 10.1016/j.heliyon.2024.e39917. eCollection 2024 Nov 15.
9
Review of Gold Nanoparticles: Synthesis, Properties, Shapes, Cellular Uptake, Targeting, Release Mechanisms and Applications in Drug Delivery and Therapy.金纳米颗粒综述:合成、性质、形状、细胞摄取、靶向性、释放机制以及在药物递送与治疗中的应用
Pharmaceutics. 2024 Oct 16;16(10):1332. doi: 10.3390/pharmaceutics16101332.
10
pH-Sensitive In Situ Gel of Mirtazapine Invasomes for Rectal Drug Delivery: Protruded Bioavailability and Anti-Depressant Efficacy.用于直肠给药的米氮平泡囊pH敏感原位凝胶:突出的生物利用度和抗抑郁疗效。
Pharmaceuticals (Basel). 2024 Jul 24;17(8):978. doi: 10.3390/ph17080978.
载拓扑替康的 SLN 热敏水凝胶系统的研制、表征及作为生物大分子用于结直肠给药的评价。
Biomed Res Int. 2021 Jul 3;2021:9968602. doi: 10.1155/2021/9968602. eCollection 2021.
4
Rectal diclofenac versus high-dose rectal acetaminophen in children: A randomized clinical trial.儿童直肠用双氯芬酸与大剂量直肠用对乙酰氨基酚的对比:一项随机临床试验。
Caspian J Intern Med. 2021 Mar;12(2):207-215. doi: 10.22088/cjim.12.2.207.
5
Particle and Gel Characterization of Irinotecan-Loaded Double-Reverse Thermosensitive Hydrogel.载有伊立替康的双相温敏水凝胶的颗粒与凝胶特性
Polymers (Basel). 2021 Feb 13;13(4):551. doi: 10.3390/polym13040551.
6
Topiramate rectal suspensions in pediatric patients.**标题**:直肠用托吡酯混悬液在儿科患者中的应用。
Seizure. 2021 Feb;85:45-47. doi: 10.1016/j.seizure.2020.12.022. Epub 2021 Jan 2.
7
Cellulose-Based Hydrogels as Sustained Drug-Delivery Systems.基于纤维素的水凝胶作为持续给药系统
Materials (Basel). 2020 Nov 21;13(22):5270. doi: 10.3390/ma13225270.
8
Recent advances in colon drug delivery systems.结肠递药系统的最新进展。
J Control Release. 2020 Nov 10;327:703-724. doi: 10.1016/j.jconrel.2020.09.026. Epub 2020 Sep 14.
9
Effectiveness of a Controlled 5-FU Delivery Based on FZD10 Antibody-Conjugated Liposomes in Colorectal Cancer In vitro Models.基于FZD10抗体偶联脂质体的5-氟尿嘧啶控释给药在结直肠癌体外模型中的有效性
Pharmaceutics. 2020 Jul 10;12(7):650. doi: 10.3390/pharmaceutics12070650.
10
Physiological and Pharmaceutical Considerations for Rectal Drug Formulations.直肠给药制剂的生理学和药学考量
Front Pharmacol. 2019 Oct 16;10:1196. doi: 10.3389/fphar.2019.01196. eCollection 2019.